The methyl donor S-adenosylmethionine prevents liver hypoxia and dysregulation of mitochondrial bioenergetic function in a rat model of alcohol-induced fatty liver disease  by King, Adrienne L. et al.
Redox Biology 9 (2016) 188–197Contents lists available at ScienceDirectRedox Biologyhttp://d
2213-23
Abbre
factor 1
reactive
n Corr
United
E-m
telishas
cegrigue
1 Eq
2 Cu
3 Cujournal homepage: www.elsevier.com/locate/redoxResearch PaperThe methyl donor S-adenosylmethionine prevents liver hypoxia and
dysregulation of mitochondrial bioenergetic function in a rat model
of alcohol-induced fatty liver disease
Adrienne L. King a,1,2, Sudheer K. Mantena a,1, Kelly K. Andringa a,
Telisha Millender-Swain a,b, Kimberly J. Dunham-Snary b,3, Claudia R. Oliva c,
Corinne E. Griguer c, Shannon M. Bailey a,b,n
a Departments of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, United States
b Departments of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, United States
c Departments of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, United Statesa r t i c l e i n f o
Article history:
Received 22 July 2016
Received in revised form
15 August 2016
Accepted 16 August 2016
Available online 17 August 2016
Keywords:
Liver
Alcohol
S-Adenosylmethionine
Mitochondria
Hypoxia
Nitric oxidex.doi.org/10.1016/j.redox.2016.08.005
17/& 2016 The Authors. Published by Elsevier
viations: ALT, alanine aminotransferase; CN-P
alpha; iNOS, inducible nitric oxide synthase; M
nitrogen species; ROS, reactive oxygen speci
esponding author at: Department of Patholog
States.
ail addresses: aking125@kennesaw.edu (A.L. K
wain@uabmc.edu (T. Millender-Swain), Kimbe
r@uabmc.edu (C.E. Griguer), shannonbailey@
ual contributions from ALK and SKM.
rrent address: Department of Biology and Pu
rrent address: Department of Medicine, Quea b s t r a c t
Background: Mitochondrial dysfunction and bioenergetic stress play an important role in the etiology of
alcoholic liver disease. Previous studies from our laboratory show that the primary methyl donor S-
Adenosylmethionine (SAM) minimizes alcohol-induced disruptions in several mitochondrial functions in
the liver. Herein, we expand on these earlier observations to determine whether the beneﬁcial actions of
SAM against alcohol toxicity extend to changes in the responsiveness of mitochondrial respiration to
inhibition by nitric oxide (NO), induction of the mitochondrial permeability transition (MPT) pore, and
the hypoxic state of the liver.
Methods: For this, male Sprague-Dawley rats were pair-fed control and alcohol-containing liquid diets
with and without SAM for 5 weeks and liver hypoxia, mitochondrial respiration, MPT pore induction, and
NO-dependent control of respiration were examined.
Results: Chronic alcohol feeding signiﬁcantly enhanced liver hypoxia, whereas SAM supplementation
attenuated hypoxia in livers of alcohol-fed rats. SAM supplementation prevented alcohol-mediated de-
creases in mitochondrial state 3 respiration and cytochrome c oxidase activity. Mitochondria isolated
from livers of alcohol-fed rats were more sensitive to calcium-mediated MPT pore induction (i.e., mi-
tochondrial swelling) than mitochondria from pair-fed controls, whereas SAM treatment normalized
sensitivity for calcium-induced swelling in mitochondria from alcohol-fed rats. Liver mitochondria from
alcohol-fed rats showed increased sensitivity to NO-dependent inhibition of respiration compared with
pair-fed controls. In contrast, mitochondria isolated from the livers of SAM treated alcohol-fed rats
showed no change in the sensitivity to NO-mediated inhibition of respiration.
Conclusion: Collectively, these ﬁndings indicate that the hepato-protective effects of SAM against alcohol
toxicity are mediated, in part, through a mitochondrial mechanism involving preservation of key mi-
tochondrial bioenergetic parameters and the attenuation of hypoxic stress.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Chronic and heavy alcohol (ethanol) consumption remains a
signiﬁcant cause of worldwide morbidity and mortality, remaining
a top ten cause of preventable death in the United States [1]. Al-
cohol is a major causative factor for many diseases, including liver
and heart disease, cancer, neurological impairments and other
mental health problems, and alcohol dependence. Alcoholic liver
disease is the number one cause of death from alcohol consump-
tion [2]. Regrettably, there are still very few effective treatments
for patients afﬂicted with this serious liver disease. As such, in-
tensive basic science research efforts still remain at the forefront
to identify the molecular underpinnings of alcohol-induced liver
injury.
The etiology of alcoholic liver disease is highly complex invol-
ving different disease stages (i.e., steatosis, steatohepatitis, ﬁbrosis,
and cirrhosis), as well as disruptions in multiple liver cell types,
metabolic and signaling pathways, and sub-cellular organelle
function. Notably, no single underlying causative factor has been
identiﬁed for alcoholic liver disease. One early target of alcohol
toxicity in the liver is the mitochondrion. Our laboratory and
others have reported that hepatic mitochondrial function, speci-
ﬁcally bioenergetic function, is signiﬁcantly impaired by chronic
alcohol drinking in animal models. For example, chronic alcohol
consumption depresses hepatic mitochondrial bioenergetics, in-
creases mitochondrial reactive oxygen species (ROS) production,
and increases sensitivity of the mitochondrial permeability tran-
sition (MPT) pore in rat and mice models of alcohol drinking [3–7].
Hepatocyte death is a direct consequence of impaired bioener-
getics, as too little energy is made by mitochondria to fuel meta-
bolism and critical cellular repair mechanisms [8]. Hepatocyte
death also is a main trigger for progression from steatosis to al-
coholic steatohepatitis [9]. Taken together, these ﬁndings reinforce
the need to more fully understand the role of mitochondrial da-
mage in alcoholic liver disease.
As the recognition of mitochondrial dysfunction in alcoholic
liver disease has grown, there is an expanding list of pharmaco-
logical agents being tested in experimental animal models of al-
cohol toxicity. For example, the aldehyde dehydrogenase 2 acti-
vator, Alda-1, reverses alcohol-induced steatosis and attenuates
apoptosis [10]. The mitochondrial-targeted antioxidant MitoQ re-
duces steatosis, mitochondrial ROS production, and ROS-depen-
dent hypoxia inducible factor 1-alpha (HIF1α) stabilization during
alcohol consumption [11]. Along these same lines, the methyl
donors betaine and S-Adenosylmethionine (SAM) offer protection
against alcohol hepatotoxicity, presumably by mitochondrial me-
chanisms [12–14]. Previously, we reported that SAM supple-
mentation attenuates mitochondrial ROS production, mtDNA da-
mage, and the alcohol-mediated increase in inducible nitric oxide
synthase (iNOS) in the liver [13]. Consequently, mitochondrial re-
spiratory function in liver from alcohol-fed rats is maintained by
SAM supplementation. Even with this knowledge, we still have an
incomplete understanding of how SAM protects against alcohol-
mediated mitochondrial dysfunction. Therefore, in the present
study we expanded on our previous analyses [13,15] to include a
more in-depth assessment of alcohol and SAM treatment on he-
patic mitochondrial bioenergetics. Accordingly, studies were un-
dertaken to determine whether the increased sensitivity of mi-
tochondrial respiration to inhibition by nitric oxide (NO) in liver
mitochondria from alcohol-fed animals was altered by SAM
treatment. Further, we assessed whether SAM supplementation
attenuates alcohol-mediated increased sensitivity to undergo the
MPT and/or diminishes alcohol-induced liver hypoxia.2. Methods
2.1. Alcohol feeding protocol
Male Sprague-Dawley rats (200–220 g, Charles River Labora-
tories, San Diego, CA) were individually housed and acclimated to
laboratory rat chow for 1 week before starting the experimental
diets. Nutritionally adequate Lieber-DeCarli control and ethanol
containing liquid diets [16] were purchased from Bio-Serv
(Frenchtown, NJ). The ethanol diet contains 36% of total daily
calories as ethanol, 35% as fat, 18% as protein and 11% as carbo-
hydrate. Control rats were fed an identical diet except ethanol
calories were substituted with dextrin maltose. Controls were
pair-fed so that each pair (control and ethanol) was iso-caloric. A
second set of animals were also pair-fed control and ethanol diets
supplemented with SAM (0.8 mg active SAM/mL diet) as described
previously [15]. Rats were maintained on diets for at least 31 days
before experiments to induce fatty liver disease. Serum blood al-
cohol and alanine aminotransferase (ALT) levels were measured
using spectrophotometric-based assays (Pointe Scientiﬁc, Inc.,
Canton, MI). Animal protocols were approved by the Institutional
Animal Care and Use Committee at the University of Alabama at
Birmingham, and animals received humane care in accordance
with the National Institutes of Health (NIH) Guide for the Care and
Use of Laboratory Animals (NIH Publication No. 86-23).
2.2. Liver hypoxia assessment - immunohistochemistry for pimoni-
dazole adducts
Liver hypoxia was assessed using the hypoxia-sensitive marker
pimonidazole (Chemicon International, Billerica, MA) as described
in [17]. Rats were injected with pimonidazole (60 mg/kg in saline,
i.p.) and after 1 h livers were harvested and processed for im-
munohistochemistry. Formalin-ﬁxed sections were deparifﬁnized
in xylene and rehydrated through incubations in graded ethanol
concentrations. Liver sections were incubated with 5% (w/v) BSA in
Tris Buffered Saline-Tween 20 for 10 min followed by 1:50 dilution
of pimonidazole-1MAb1 conjugated with FITC for 1 h. Slides were
washed, incubated for 1 h with anti-FITC conjugated with HRP,
and bound antibody was visualized with DAB chromagen followed
by hematoxylin nuclear counterstain. Positive pimonidazole pro-
tein adduct staining was visualized by brown staining, and the
area of staining was quantiﬁed using ImageJ (National Institutes of
Health, Bethesda, MD).
2.3. Liver mitochondria isolation and measurement of respiratory
function
Mitochondria were prepared by differential centrifugation of
liver homogenates using ice-cold mitochondria isolation buffer
containing 250 mM sucrose, 1 mM EDTA, and 5 mM Tris–HCl, pH
7.5 [18]. Protease inhibitors were added to the isolation buffer to
prevent protein degradation. Respiration rates were measured
using a Clark-type O2 electrode (Oxygraph, Hansatech Instruments
Limited, Norfolk, UK). Mitochondria were incubated in respiration
buffer containing 130 mM KCl, 3 mM HEPES, 1 mM EGTA, 2 mM
MgCl2, and 2 mM KH2PO4, pH 7.2. Respiratory function was as-
sessed by measuring state 3 and 4 respiration rates using 15 mM
succinate/5 mM rotenone and 0.5 mM ADP to stimulate state 3 re-
spiration. Coupling was determined by calculating the respiratory
control ratio, which is deﬁned as state 3 (ADP-dependent) divided
by state 4 (ADP-independent) respiration. As reported previously,
mitochondrial protein yield per liver and citrate synthase activities
were unaltered by ethanol, SAM, or both treatments [13,15].
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Activities of respiratory Complex I (NADH dehydrogenase) and
Complex IV (cytochrome c oxidase) were measured using clear
native polyacrylamide gel electrophoresis (CN-PAGE) for in-gel
activity assays [19,20]. Preparation of mitochondrial samples and
methods used for the separation of complexes by CN-PAGE were
similar to those described previously [15, 21], except protein ex-
tracts were mixed with Ponceau S (50% w/v glycerol, 0.1% w/v)
before electrophoresis. Gels were run overnight (4 °C) at constant
30 V to separate complexes. After electrophoresis, gels were in-
cubated with substrates at room temperature and reactions were
stopped by ﬁxing gels in a 50% v/v methanol and 10% v/v acetic
acid solution. Loading different amounts of protein and varying
incubation times achieved optimization for visualization of in-gel
activities. After optimization, samples (0.2 mg protein) from all
experimental groups were run on each gel. For Complex I activity
staining, gels were incubated for 5 min in 100 mL of 5 mM Tris–
HCl, pH 7.4, containing 0.1 mg/mL NADH and 1.25 mg/mL nitroblue
tetrazolium. For Complex IV activity staining, gels were incubated
for 45 min in 100 mL of 50 mM sodium phosphate, pH 7.2, con-
taining 0.05% w/v DAB chromagen and 50 mM horse heart
cytochrome c. Following reactions and ﬁxations, gels were stored
in 10% v/v acetic acid. Gels were imaged and analyzed using
a Bio-Rad Chemi-Doc Imager with Quantity One software (Bio-Rad
Laboratories, Hercules, CA).
2.5. Mitochondrial permeability transition pore formation – swelling
assay
MPT pore formation was assessed as the degree of calcium
(Ca2þ)-induced swelling and was measured spectro-
photometrically (540 nm) as described previously [6,22,23]. The
change in absorbance after Ca2þ addition was used to quantify
degree of swelling. Isolated liver mitochondria were depleted of
Ca2þ by 15 min incubation in Ca2þ depletion buffer (1 mM EGTA,
10 mM NaCl, 5 mM succinate). Mitochondria (1 mg/mL) were
suspended in 1.0 mL of swelling buffer (195 mM mannitol, 25 mM
sucrose, 40 mM HEPES) plus 5 mM succinate and 1 mM rotenone,
pH 7.2. After 2 min incubation in the spectrophotometer, 100 mM
Ca2þ was added to initiate MTP opening and swelling (decrease in
absorbance) was monitored for 20 min.
2.6. Evaluation of nitric oxide (NO)-dependent control of mitochon-
drial respiration
The effect of exogenous NO on mitochondrial respiration was
studied using a closed chambered oxygraph respirometer (Or-
oboros, Innsbruck, Austria) essentially as described in [17,24,25].
The respirometer chambers were modiﬁed to accommodate a NO
sensor (ISO-NOP, World Precision Instruments, Sarasota, FL) for
simultaneous real-time measurements of O2 and NO concentra-
tions. The O2 sensor signal, calibrated in 100% air equilibrated re-
spiration buffer, was converted to μM O2 by the respirometer-
speciﬁc software (DatLab) using the O2 solubility of the buffer and
daily barometric pressure. The NO sensor was calibrated before
each experiment using a fast releasing NO donor, PROLI NONOate
(t½¼1.3 s), over a concentration range of 1.25–5.0 μM at low O2
levels. The NO sensor signal in nA was recorded with a free radical
analyzer (Apollo 4000, WPI, Sarasota FL) and converted to μM NO
using the generated NO calibration curve.
For experiments, mitochondria (0.5 mg/mL) were injected into
the chambers and mixed with air-equilibrated respiration buffer
(200 μM O2), succinate/rotenone (15 mM/5 μM), and ADP
(0.5 mM) to start state 3 respiration. After a baseline rate of re-
spiration was attained, the NO donor (PAPA NONOate, 5 μM,t½¼15 min) was added at 160 μM O2 (80% O2 saturation). This
resulted in NO release and gradual inhibition of respiration. The
acquired NO concentration traces were corrected for baseline and
aligned to corresponding O2 traces in order to plot the O2 con-
sumption rates, calculated as derivatives of the O2 concentration
versus time traces, and normalized to the maximum respiration
rate, as a function of NO concentration [17].
2.7. Statistical Analysis
Two-factor ANOVA and Student's t-tests were performed using
KaleidaGraph software version 4.0 (Synergy Software, Reading PA)
with statistical signiﬁcance set at po0.05. For ANOVA, the main
effect factors are deﬁned as diet (control vs. ethanol), SAM effect
(absent vs. present), and interaction (ethanol X SAM). The sample
size ranged from three to eight rats per treatment group.3. Results
3.1. Animals and markers of liver injury
Addition of SAM to the control and ethanol-containing diets
had no effect on the total amount of the liquid diets consumed by
rats (data not shown), and weight gain during the feeding protocol
(Weight gain: control, 10579; ethanol, 96711; controlþSAM,
10379; and ethanolþSAM, 10377 g). While rats fed the ethanol
diet alone gained slightly less weight than the other groups this
difference was not statistically different (2-factor ANOVA: diet
effect, p¼0.6; SAM effect, p¼0.8; interaction, p¼0.60). Moreover,
there was no difference in blood alcohol concentration between
the ethanol and ethanolþSAM groups (Blood alcohol concentra-
tion: ethanol, 153720 and ethanol7SAM, 142718 mg/dL,
p¼0.70). Previously, we reported that SAM co-administration
modestly decreases ethanol-mediated fat accumulation and in-
ﬂammation in liver [15]. In the current study we observed similar
results on histopathology (data not shown) and serum ALT levels.
For example, ethanol feeding increased serum levels of ALT com-
pared to control groups with lower ALT levels measured in the
ethanolþSAM group (Serum ALT: control, 3773; ethanol
102735; controlþSAM, 4072; ethanolþSAM, 6775 IU/L). Two-
factor ANOVA showed a statistically signiﬁcant effect of ethanol
with no effect of SAM on serum ALT levels (diet effect, p¼0.02;
SAM effect, p¼0.4, interaction, p¼0.3).
3.2. SAM attenuates ethanol-mediated hypoxia
Early studies indicate that hypoxia is increased by both acute
and chronic ethanol consumption and contributes to hepatotoxi-
city [26,27]. However, what is not known is whether the hepato-
protective effects of SAM can be linked to attenuation of ethanol-
mediated hypoxia. To address this question, the hypoxia marker
chemical pimonidazole was used to assess the degree of liver hy-
poxia. Pimonidazole is reductively activated and covalently binds
to macromolecules, most likely proteins, at low pO2 to form ad-
ducts that can be detected via an antibody directed against the
pimonidazole adduct [28]. Using an immunohistochemistry ap-
proach, we observed a signiﬁcant increase in pimonidazole stain-
ing (i.e., brown staining) in the liver of ethanol fed rats that ex-
tended out from the centrilobular (i.e., zone 3) region into the
midzonal and periportal regions of liver as compared to control
(Fig. 1A). In contrast, the extent of pimonidazole staining was
signiﬁcantly reduced in the ethanolþSAM group and approached
control levels (Fig. 1A). Quantiﬁcation of the percent area for pi-
monidazole staining showed approximately 25% coverage of the
lobule in liver from ethanol-fed animals versus only 10% in the
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Fig. 1. S-Adenosylmethionine (SAM) prevents alcohol-mediated increase in liver hypoxia. (A) Representative photomicrographs showing pimonidazole adduct formation
(brown staining) against hematoxylin counterstain (blue stained nuclei) in liver from rats fed control (a), ethanol (b), controlþSAM (c), and ethanolþSAM (d) diets. The
increased pimonidazole (brown) staining in the ethanol group (b) demonstrates increased tissue hypoxia compared to all other groups. (B) Image analysis shows increased
area of pimonidazole adduct formation (i.e., hypoxia) in liver from ethanol fed rats (b) compared to control (a) whereas addition of SAM to the ethanol diet prevented
ethanol-mediated hypoxia (compare panels b and d). Data represent the mean7SEM for three pairs per group. *po0.05, compared to corresponding control; **po0.05,
compared to ethanol. Two-factor ANOVA; Diet, p¼0.0007; SAM, p¼0.0015; and Interaction, p¼0.013. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
A.L. King et al. / Redox Biology 9 (2016) 188–197 191
Table 1
S-Adenosylmethionine (SAM) preserves liver mitochondrial respiration during
chronic alcohol.
Treatment State 31 State 4 RCR2
Control 0.16070.009 0.04670.002 3.4770.15
Ethanol 0.11770.007* 0.04870.003 2.5470.11*
ControlþSAM 0.25270.009*,** 0.06570.003* 4.0270.07*
EthanolþSAM 0.19370.011**,*** 0.05270.002 3.6170.05**,***
ANOVA (p values)3
Diet effect o0.0001 0.0479 o0.0001
SAM effect o0.0001 o0.0001 o0.0001
Interaction 0.376 0.0129 0.0126
Mitochondrial respiration was measured using the complex II-linked substrate
succinate.
Data represented as mean7SEM for n¼8 animals per treatment group.
* po0.05, compared to Control.
** po0.05, compared to Ethanol.
*** po0.05, compared to ControlþSAM.
1 Oxygen utilization for state 3 and 4 respiration expressed as μg atom oxygen
consumed/min/mg protein.
2 RCR – respiratory control ratio (state 3 respiration/state 4 respiration).
3 Results from 2-Factor ANOVAwith Diet effect (control vs. ethanol), SAM effect
(absent vs. present), and Interaction (Ethanol X SAM).
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controls. These results demonstrate that SAM attenuates ethanol-
induced hypoxia in the liver.1000
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To ascertain whether SAM prevents ethanol-mediated loss in
mitochondrial respiratory capacity, oxygen consumption was
measured using standard respirometry techniques [18]. Using
succinate, a complex II-linked oxidizable substrate, we observed a
signiﬁcant decrease in state 3 respiration and the respiratory
control ratio (RCR) in mitochondria isolated from livers of ethanol-
fed animals compared to controls (Table 1). The RCR is an indicator
of the tightness of coupling between respiration (i.e., electron
transport) and oxidative phosphorylation (i.e., ATP synthesis).
Therefore, a decrease in the RCR indicates less coupled mi-
tochondria and decreased ATP synthesis in liver mitochondria
from ethanol-fed rats. State 3 respiration and the RCR were
maintained at control levels in mitochondria from the etha-
nolþSAM group (Table 1).
3.4. SAM preserves respiratory Complex I and IV activities in liver of
ethanol-fed rats
To determine whether maintenance of respiration by SAM in
the ethanol-fed rats was linked to the respiratory complex activity,
we measured Complex I and IV activities. We were able to visua-
lize and quantify the activities of Complex I and IV of our liver0
00
00
00
00
0
000
000
000
000
*
*
**
Complex I
Complex IV
Control Ethanol Control
+ SAM
Ethanol 
+ SAM
Control Ethanol Control
+ SAM
Ethanol 
+ SAM
ronic alcohol consumption. Liver mitochondria (0.2 mg) was separated using clear
ivity assays. Representative gels showing activities of Complex I (A) and Complex IV
ted rats. (B, D) Quantiﬁcation of Complex I and IV activities within the gel. Data
ponding control, **po0.01, compared to ethanol. Two-factor ANOVA for Complex I;
x IV; Diet, p¼0.004; SAM, p¼0.013; and Interaction, p¼0.005.
0.0
0.3
0.6
0.9
1.2
0 300 600 900 1200
Seconds
A.
Con
Con + Ca+2
EtOH
EtOH + Ca+2
0.0
0.3
0.6
0.9
1.2
0 300 600 900 1200
Seconds
Con + SAM
Con + SAM + Ca+2
EtOH + SAM
EtOH + SAM + Ca+2
B.
A
bs
 (5
40
 n
m
)
A
bs
 (5
40
 n
m
)
0
40
80
120
160
200
Pe
rc
en
t s
w
el
lin
g
C.
Control Ethanol Control
+ SAM
Ethanol
+ SAM
*
**
Fig. 3. S-Adenosylmethionine (SAM) prevents ethanol-associated increase in sen-
sitivity to calcium-induced mitochondrial swelling. Liver mitochondria (1.0 mg/mL)
from control and ethanol (A) and controlþSAM and ethanolþSAM (B) treated
animals were incubated in the spectrophotometer and calcium (Ca2þ) was added
(dashed lines) at 2 min to induce mitochondrial swelling indicated by a decrease in
absorbance at 540 nm. Solid lines are in the absence of Ca2þ . (C) Quantiﬁcation of
mitochondrial swelling. The immediate change in absorbance (slope) after the
addition of Ca2þ was calculated and used to determine the extent of swelling.
Results are presented as percent change from control set at 100%. Data represent
the mean7SEM for ﬁve pairs per group. *po0.05, compared to control, **po0.05,
compared to ethanol. Two-factor ANOVA; Diet, p¼0.048; SAM, p¼0.023; and In-
teraction, p¼0.043.
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established in-gel activity assay format (Fig. 2). As expected,
chronic alcohol consumption alone signiﬁcantly decreased the
activities of Complex I and IV compared to samples from control-
fed rats (Fig. 2A and C). Complex IV activity was maintained in the
ethanolþSAM group and did not differ from activities measured in
the control groups (Fig. 2C and D). While Complex I activity was
higher in the ethanolþSAM group compared to the ethanol alone
group this did not reach statistical signiﬁcance (Fig. 2A and B).
Together, these results support the idea that SAM supplementation
prevents a loss in respiratory complex activity during chronic
ethanol feeding, which preserves hepatic respiratory function of
mitochondria.
3.5. SAM prevents the ethanol-mediated increase in sensitivity to
undergo the mitochondrial permeability transition
To extend investigations into the effect of ethanol and SAM on
mitochondrial function, experiments were performed to de-
termine responses to Ca2þ-mediated induction of the MPT pore.
For this, we monitored mitochondrial swelling spectro-
photometrically in response to Ca2þ . Mitochondria from all
treatment groups showed swelling (i.e., decrease in absorbance) in
response to Ca2þ (dashed lines) with little change in absorbance
observed in mitochondria incubated in the absence of Ca2þ (solid
lines) (Fig. 3A and B). Mitochondria from ethanol-fed animals
showed a greater degree of swelling compared to corresponding
controls (Fig. 3A and C). Notably, this increased sensitivity to Ca2þ-
induced swelling was absent in mitochondria from the etha-
nolþSAM group (Fig. 3B and C). Inclusion of cyclosporin A (CsA,
1 mM), which inhibits MPT pore opening by binding to the pro-
posed regulatory protein cyclophilin D blocked Ca2þ-mediated
swelling in all groups (results not shown). These results provide
further evidence that the hepato-protective effects of SAM against
alcohol toxicity can be attributed, in part, to preservation in var-
ious mitochondrial functions.
3.6. SAM prevents ethanol-mediated increased sensitivity to nitric
oxide-mediated inhibition of respiration
To determine whether SAM preserves NO-control of respiration
during chronic alcohol consumption, we assessed NO-dependent
inhibition of mitochondrial respiration using high-resolution re-
spirometry. Oxygen traces from a representative experiment using
mitochondria from a control animal are shown in Fig. 4A. For these
measurements, mitochondria are incubated in the respirometer
chamber with succinate and state 3 respiration is initiated by the
addition of ADP. When the O2 concentration in the chamber
reaches approximately 80% of the initial O2 concentration, ap-
proximately 160 mM O2, the NO donor PAPA NONOate was added
(see arrow, panel A), which causes an inhibition of mitochondrial
respiration (solid line, panel A). In the absence of PAPA NONOate, a
constant rate of O2 consumption is observed until O2 is depleted
(dashed line, panel A). In these experiments there was no differ-
ence in the amount or rate of NO produced from PAPA NONOate in
mitochondria from all treatment groups indicating equal rates of
NO consumption and that addition of oxyhemoglobin, a NO sca-
venger, restores respiration to pre-NO rates of O2 consumption
(results not shown).
To quantify the difference in sensitivity of mitochondrial re-
spiration to NO among treatment groups, the respiration rate was
calculated as the instantaneous derivative of the O2 concentration
trace (Fig. 4A) and plotted as a function of NO concentration, and
recorded simultaneously by the NO sensor following the bolus
addition of PAPA NONOate. As shown in Fig. 4B, mitochondriaisolated from the livers of ethanol-fed rats were more sensitive to
the inhibitory effects of NO as evident by the leftward-shift in the
NO concentration versus respiration rate dose-response curve. In
contrast, the NO-respiration curve for the ethanolþSAM group
was not different from control. The NO concentration required to
elicit a 50% inhibition in respiration (i.e., IC50) decreased by 46%
from 0.3070.02 mM in control to 0.1670.03 mM in ethanol. In
comparison, the IC50 only decreased by 15% from 0.3270.02 mM in
controlþSAM to 0.2770.04 mM in ethanolþSAM (Fig. 4C). This
result shows that SAM largely prevents the ethanol-mediated in-
crease in sensitivity to NO-mediated inhibition of mitochondrial
respiration.
020
40
60
80
100
120
0 0.2 0.4 0.6 0.8 1
R
es
pi
ra
tio
n 
ra
te
 (%
 o
f m
ax
) Control
Ethanol
Control + SAM
Ethanol + SAM
NO (µM)
B.
0.00
0.10
0.20
0.30
0.40
IC
50
 fo
r N
O
Control Ethanol Control
+ SAM
Ethanol
+ SAM
*
*,**(µM
)
0
50
100
150
200
0 50 100 150 200 250 300 350
Mitochondria, Succinate
ADP
NONOate
Time (sec)
O
2
(µ
M
)
Control + NO
Control
A.
C.
Fig. 4. S-Adenosylmethionine (SAM) prevents alcohol-mediated increased sensi-
tivity to nitric oxide-mediated inhibition of mitochondrial respiration.
(A) Representative respiration experiment with liver mitochondria (0.5 mg/mL)
from a control fed animal incubated with succinate/rotenone (15 mM/5 mM) and
ADP (0.5 mM). Oxygen concentration traces are shown in the absence (black da-
shed line) and presence (black solid line) of PAPA NONOate (5 mM), which was
added to the respirometer chamber at approximately 80% O2 saturation (160 mM
O2). There was no difference in the rate or amount of NO produced among the four
treatment groups (results not shown). (B). Trace of respiration rate, % of maximum,
plotted as a function of NO concentration with mitochondria isolated from liver of
control (black solid line), ethanol (gray solid line), controlþSAM (black dashed
line), and ethanolþSAM (gray dashed line) fed rats. In these experiments, both O2
and NO concentrations are measured simultaneously for the duration of each re-
spiration measurement. (C) Presented is the concentration of NO that results in a
50% decrease in the mitochondrial respiration rate (inhibitory concentration 50,
IC50) for the four treatment groups. Note that there is a large decrease in the IC50 for
ethanol group compared to control, which is attenuated in the ethanolþSAM
group. Data represent the mean7SEM for six pairs per group. *po0.05, compared
to corresponding control, **po0.05, compared to ethanol. Two-factor ANOVA;
Diet, p¼0.009; SAM, p¼0.054; and Interaction, p¼0.31.
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Mitochondria provide the majority of energy required to fuel
cellular metabolism and repair reactions in most organs. They
mediate the controlled production of ROS for redox signaling,regulate intracellular Ca2þ homeostasis, and serve as gatekeepers
for apoptotic and necrotic cell death pathways. Further high-
lighting the importance of the mitochondrion in maintaining cel-
lular physiology and health is the fact that dysregulated mi-
tochondrial function underlies numerous diseases, including al-
coholic liver disease. Therefore, improved understanding of the
role of mitochondrial dysfunction in the etiology of alcoholic liver
disease remains an intense area of investigation.
Conﬁrming previous studies from our laboratory [6,7], we ob-
served that chronic alcohol consumption disrupts several key
mitochondrial bioenergetic parameters in rat liver. Chronic alcohol
intake decreases mitochondrial oxygen consumption and in-
creases the susceptibility of mitochondria to induce formation of
the MPT pore, a key component of cell death programs. We also
validated that supplementation of the alcohol-containing diet
with SAM preserves hepatic mitochondrial respiratory function
(Table 1) and cytochrome c oxidase activities at levels similar to
those measured in livers of control rats (Fig. 2). While the mole-
cular mechanism(s) underlying these protective effects on re-
spiratory function is unknown, we and others have shown that
SAM supplementation has a signiﬁcant impact on the mitochon-
drial proteome [12,15], prevents alcohol-mediated mtDNA damage
[13] and mitoribosome dissociation [29]. SAM prevents the alco-
hol-mediated decrease in select Complex I and IV subunits [13,15].
We propose this as a component of the mechanism by which SAM
maintains mitochondrial respiratory during chronic alcohol con-
sumption. We have also shown that the methyl donor betaine
prevents alcohol-mediated losses in respiratory chain proteins
[14]. Herein, we observed that SAM also decreases alcohol-induced
liver injury as serum ALT levels were lower in alcohol-fed rats
supplemented with SAM compared to ALT levels measured in
rats fed alcohol alone. These ﬁndings support previous studies
demonstrating that SAM and other methionine metabolism
intermediates decrease alcohol-induced steatosis and liver injury
[30–32].
Several investigators have described the importance of NO in
alcohol hepatotoxicity. It is widely accepted that generation of the
reactive nitrogen species (RNS) peroxynitrite (ONOO-) during con-
ditions of elevated superoxide anion (O2-) and NO production (as
in the case of chronic alcohol consumption) causes mitochondrial
dysfunction through post-translational modiﬁcation (e.g., cysteine
oxidation and tyrosine nitration) and subsequent inactivation of
mitochondrial proteins [33,34]. Indeed, studies from our lab and
others show oxidative modiﬁcation of mitochondrial protein cy-
steinyl groups in the livers of rats chronically fed alcohol [35,36].
Increased mitochondrial ROS production occurs as a consequence of
alcohol-mediated alterations to the respiratory chain [3,7,37] and
increased iNOS occurs in response to upregulation of pro-in-
ﬂammatory mediators during chronic alcohol consumption
[25,38,39]. Additionally, NO is a key regulator of mitochondrial re-
spiration through its ability to inhibit cytochrome c oxidase activity
and O2 consumption [40,41]. While the physiologic signiﬁcance of
this NO-cytochrome c oxidase interaction remains poorly deﬁned, it
is speculated that controlling respiratory function at the level of
Complex IV can affect tissue O2 gradients and ROS production from
mitochondria [42,43]. Within this context, we hypothesize that
dysregulation of the NO-mitochondria signaling axis contributes, in
part, to alcohol-induced hepatotoxicity.
Previously, we reported that chronic consumption of an alcohol
diet [24,39] or a high fat diet [17] increases the sensitivity of he-
patic mitochondrial respiration to inhibition by NO. Importantly,
this alcohol-dependent alteration in the function of Complex IV is
iNOS-dependent. We found that the alcohol-dependent increase in
the sensitivity of respiration to inhibition by NO is not observed in
liver mitochondria isolated from iNOS knockout mice chronically
fed the alcohol diet [25]. This result implicates a major role of NO
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nergetic responsiveness, which we propose is due to NO-mediated
posttranslational modiﬁcations to Complex IV, other regulatory
components of the respiratory chain, and/or other mitochondrial
proteins.
Interestingly, we have also revealed that alcohol-mediated
hypoxia is attenuated in livers of alcohol-fed iNOS knockout mice
[39], which again supports an important role for NO-derived iNOS
in alcohol-induced hypoxic stress and injury. Herein, we show for
the ﬁrst time similar responses with the pharmacological inter-
vention of SAM. Hypoxia was signiﬁcantly blunted in the livers of
alcohol-fed rats treated with SAM (Fig. 1). Additionally, the alco-
hol-dependent increase in NO sensitivity was not detected in liver
mitochondria isolated from alcohol-fed rats co-administered SAM
(Fig. 4). Of importance, our group and others have reported that
SAM blocks hepatic iNOS induction in alcohol feeding models
[13,44,45]. Similar ﬁndings (decreased iNOS) have been reported
for betaine in alcohol feeding models [14] and for SAM in an LPS
model of inﬂammation [46]. The latter study showed that SAM
normalized the methylation status of the iNOS promoter, which
prevented iNOS induction [46]. Whether this SAM-mediated ac-
tion occurs in response to chronic alcohol feeding requires further
investigation. Collectively, these data strongly support a role for
iNOS and the ensuing chronic exposure to NO in alcohol-induced
mitochondrial dysfunction.
Multiple studies have shown that inhibiting the ability of mi-
tochondria to undergo MPT prevents or lessens the extent of mi-
tochondrial and tissue damage in a large number of organs sys-
tems [47,48]. As such, we investigated whether SAM supple-
mentation alters MPT sensitivity in liver mitochondria from alco-
hol-fed rats. For these studies, we used the classic Ca2þ-induced
mitochondrial swelling assay [49]. We observed that SAM had no
effect on Ca2þ-induced swelling in liver mitochondria from con-
trol-fed rats (Fig. 3). As expected, mitochondria isolated from the
livers of alcohol-fed rats are the most sensitive group to Ca2þ-
induced swelling. In contrast, mitochondria isolated from alcohol-
fed rats treated with SAM have similar responsiveness to Ca2þ-
induced swelling compared to mitochondria isolated from livers of
both control-fed groups (Fig. 3). In addition to Ca2þ , oxidants can
trigger and/or facilitate induction of the MPT pore. It has been
proposed that, in addition to the classic regulated MPT pore model
(i.e., a protein pore consisting of multiple mitochondrial proteins
and Cyclophilin D that is inhibited by CsA), there is a less-regu-
lated mechanism of MPT pore formation involving aggregation of
oxidized and misfolded mitochondrial membranes proteins and/or
lipids [50]. Previous studies from our laboratory suggest that both
MPT pore mechanisms are functioning in liver mitochondria fol-
lowing chronic alcohol exposure; the classic Cyclophilin D/CsA-
sensitive MPT pore and the less-regulated pore consisting of oxi-
datively-damaged proteins and lipids [23]. Taken together, we
hypothesize that SAM decreases sensitivity of the MPT pore, in
part, by attenuating oxidant damage to the mitochondrion. This
concept is supported by our earlier work showing that SAM nor-
malizes mitochondrial O2- production and iNOS levels in livers of
alcohol-fed animals [13].
In this current study, we have provided several exciting and
novel pieces of data supporting the hypothesis that SAM hepato-
protection is mediated, in part, through preservation of key mi-
tochondrial functions. Early studies on this topic examined the
possibility that SAM protection is mediated by the antioxidant
glutathione (GSH). Work by Fernandez-Checa and colleagues
showed that chronic alcohol consumption depletes hepatic mi-
tochondrial GSH in rodents [51–53]. Moreover, they showed that
adding SAM, a GSH precursor, to the ethanol diet helped to main-
tain mitochondrial GSH in the liver [54]. These ﬁndings therefore
supported the hypothesis that SAM protects mitochondria fromethanol-induced oxidative stress by preserving GSH. With this said,
however, the picture is not so clear, as several groups have reported
that mitochondrial GSH depletion is not a consistent characteristic
of chronic alcohol-induced liver injury [55–57]. For example, we
found that chronic alcohol feeding in rats causes a small increase in
mitochondrial GSH levels [13,58] with no effect of SAM [13]. Similar
results were found with betaine [14]. In these studies, we proposed
that increased mitochondrial GSH represents an adaptive physio-
logical response to the mild oxidant stress induced by chronic
alcohol consumption. Taken together, these ﬁndings suggest SAM
protection is multi-faceted and mediated by both GSH dependent
and independent pathways.
As discussed, SAM is the main cellular methyl donor and dis-
ruption in hepatic SAM metabolism occurs during chronic alcohol
consumption [59]. It is believed that one mechanism through
which SAM repletion functions to protect against toxicity and
disease is by sustaining methylation of lipids, proteins, and nucleic
acids. For example, Halsted and colleagues showed that decreases
in hepatic SAM content, hypo-methylation of genomic DNA, and
injury are absent in livers of alcohol-fed mice treated with betaine
[60]. In line with the importance of nuclear DNA methylation
status in determining health or disease, mounting evidence sug-
gests that methylation of mtDNA occurs in vivo and is altered by
disease [61]. Abnormal methylation patterns are observed in livers
of nonalcoholic steatohepatitis patients and correlated with de-
creased mitochondrial transcripts [62]. In addition to this potential
epigenetic mechanism, methylation of tRNA and rRNA is essential
for mitochondrial protein synthesis and maintenance of mi-
tochondrial function [63]. Protein methylation is a low abundance
post-translational modiﬁcation; however, Walker and colleagues
recently identiﬁed methylated proteins within the respiratory
chain [64,65]. Although no such research regarding methylation of
mtDNA and/or mitochondrial proteins has been reported in ex-
perimental or clinical alcoholic liver disease, it is conceivable that
alcohol-mediated SAM depletion could alter the mitochondrial
‘methylome’ in the liver. Therefore, future studies should be aimed
at characterizing the liver mitochondrial methylome under control
and alcohol-exposed conditions, and determining whether alco-
hol-mediated changes, if present, impact the mitochondrial bioe-
nergetic parameters examined in this study.5. Conclusion
In summary, these new data support the hypothesis that the
mitochondrion is a central player in SAM hepato-protection. We
show that SAM prevents alcohol-induced hypoxia, normalizes re-
sponsiveness for MPT pore induction, and prevents increased
sensitivity to NO-mediated inhibition of respiration. As these SAM-
mediated responses mirror those seen using the iNOS knockout
mouse model [25,39], it is likely that NO and/or other RNS derived
from iNOS mediate the damaging effects of alcohol on the mi-
tochondrion. And, while we cannot determine from the current
data whether the protective effect of SAM derives directly from
blunting NO (or RNS)-mediated toxic reactions, we do know from
previous work that SAM prevents iNOS induction [13]. Thus, we
speculate that SAM prevents alcohol-induced mitochondrial da-
mage by blocking iNOS induction in the liver. Although pre-clinical
data like those included herein show hepato-protective actions of
SAM early in the disease process, the effectiveness of SAM in
treating end-stage liver disease patients with alcoholic cirrhosis is
mixed [66,67]. However, as reviewed by Anstee and Day [68], only
a handful of small clinical trials have been performed to assess the
efﬁcacy of SAM in treating a variety of liver diseases. Therefore,
targeting methyl metabolism with SAM or related agents still re-
mains a viable therapy for treating alcoholic liver disease.
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